What steps are involved in correctly verifying blood product accuracy before transfusion?

What steps are involved in correctly verifying blood product accuracy before transfusion?

• A. Verify patient identity with two identifiers and crossmatch with the order; confirm product details before administration.
• B. Check patient identity only.
• C. Verify product name and expiration after transfusion.
• D. Crossmatch the patient with unrelated staff to confirm order.

Answer: (A)

Verifying blood product accuracy before transfusion hinges on a thorough identity and product check. Start by confirming the patient using two identifiers—typically name and date of birth—against the armband and the medical record. Then crosscheck the transfusion order with the unit label and product details, ensuring the correct blood type (including ABO/Rh), unit number, and expiration date match what was ordered and what the patient requires. This pre-administration verification catches mismatches between patient and product, labeling errors, or an expired unit before any infusion begins. Administration should proceed only after these checks are confirmed, with continued monitoring during the transfusion. Other approaches fall short because relying on identity alone misses product accuracy, checking expiration after transfusion is too late to prevent harm, and crossmatching with unrelated staff doesn’t verify the patient-to-product match or align with the order.

Verifying blood product accuracy before transfusion hinges on a thorough identity and product check. Start by confirming the patient using two identifiers—typically name and date of birth—against the armband and the medical record. Then crosscheck the transfusion order with the unit label and product details, ensuring the correct blood type (including ABO/Rh), unit number, and expiration date match what was ordered and what the patient requires. This pre-administration verification catches mismatches between patient and product, labeling errors, or an expired unit before any infusion begins. Administration should proceed only after these checks are confirmed, with continued monitoring during the transfusion.

Other approaches fall short because relying on identity alone misses product accuracy, checking expiration after transfusion is too late to prevent harm, and crossmatching with unrelated staff doesn’t verify the patient-to-product match or align with the order.